Tinnitus research and patient perspectives
Plain-language writing on tinnitus science, treatment realism, and what we're learning as we build the next generation of tinnitus care at MediSense.
Tinnitus treatment: a complete patient guide with clinical evidence (2025)
Synthesizes tinnitus clinical guidelines from the AAO-HNS (US 2014), NICE (UK 2020), and AWMF S3 (Germany 2021) — what all three recommend, where they differ, and full references.
Read article →Not all tinnitus is the same — find out which type you have before spending money on treatment
95% of tinnitus is subjective — but within that, the causes and solutions differ dramatically. A simple guide to understanding your type before choosing treatment.
Read article →How to measure your tinnitus at home: pitch matching, frequency test & THI scoring
A research-based guide to tinnitus self-assessment: pitch matching, frequency estimation, and THI/TFI scoring. Learn what these measurements mean and how to use them with your audiologist.
Read article →Menopause and tinnitus: what the research says about what to do
Tinnitus is reported by many women during perimenopause. Published research on hormonal factors, hearing evaluation, and evidence-based management options.
Read article →Caregiver stress and tinnitus: what research says about why it gets worse
Tinnitus often worsens during caregiving. Published neuroscience explains why stress amplifies tinnitus perception, and what evidence-based options clinical guidelines recommend.
Read article →Tried multiple tinnitus treatments with no results? A research-based audit
Most tinnitus treatments that don't work were mismatched to the profile, too short, or missing evidence-based combinations. An audit against published clinical trial data.
Read article →What's coming
- Plain-language summaries of major tinnitus research
- Patient interviews and lived-experience pieces
- Evidence reviews on supplements and wellness claims
- SilenEar company milestones as we move toward clinical readiness
Get early updates
We're currently in stealth mode as we build our IP portfolio. Sign up for updates to be the first to know when we publish new writing and company news.